SCHEMBL20090091

SCHEMBL20090091

O=P(c1ccc2ccccc2c1)(c1ccc2cc(-c3ccc4c5c6ccccc6ccc5c5nc6ccccc6n5c4c3)ccc2c1)c1ccc2ncccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.38
POLB P06746 2/20 0.38
RAB9A P51151 2/20 0.38
METAP2 P50579 1/20 0.36
BCL2 P10415 1/20 0.36
KMT2A Q03164 4/20 0.35
MEN1 O00255 2/20 0.35
CYP1A2 P05177 2/20 0.35
MAPT P10636 2/20 0.35
CAMKK1 Q8N5S9 2/20 0.35
CAMKK2 Q96RR4 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CASP1 P29466 1/20 0.35
CYP2C19 P33261 1/20 0.35
CASP7 P55210 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20090102 0.95 BCL2 (0.36) NPC1POLBRAB9AMETAP2BCL2
SCHEMBL20090087 0.93 BCL2 (0.40) NPC1POLBRAB9ABCL2KMT2A
SCHEMBL20090094 0.91 POLB (0.38) NPC1POLBRAB9AMETAP2BCL2
SCHEMBL20090227 0.90 NPC1 (0.36) NPC1POLBRAB9AMETAP2CYP3A4
SCHEMBL20090077 0.89 HPGD (0.41) NPC1POLBRAB9ABCL2KMT2A
SCHEMBL20090231 0.88 UTRN (0.35) NPC1POLBRAB9AMETAP2BCL2
SCHEMBL19960328 0.87 AHR (0.36) NPC1POLBRAB9ABCL2KMT2A
SCHEMBL19960324 0.86 AHR (0.36) NPC1POLBRAB9ABCL2KMT2A
SCHEMBL20090248 0.86 AHR (0.36) NPC1POLBRAB9ABCL2KMT2A
SCHEMBL20090108 0.86 HPGD (0.35) NPC1POLBRAB9ABCL2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-07-16 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 NPC1 3974/4885POLB 2517/4885RAB9A 2901/4885
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 NPC1 3974/4885POLB 2517/4885RAB9A 2901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.